Bliss GVS Pharma Limited (BLISSGVS.NS) NSE
Currency In INR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 22.76B |
| Enterprise Value | 22.63B |
| P/E Ratio | 43.41 |
| PEG Ratio | 0.96 |
| Price/Sales Ratio | 6.5 |
| Price/Book Ratio | 5.4 |
| Enterprise/Revenue | 6.48 |
| Enterprise/EBITDA | 25.64 |
Fiscal Year
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | September 30, 2026 |
Profitability
| Profit Margin | 0.15 |
| Operating Margin | 0.19 |
AD
Management Effectiveness
| Return On Assets | 0.1 |
| Return On Equity | 0.13 |
Income Statement
| Revenue | 9.27B |
| Revenue/Share | 101.14 |
| Gross Profit | 5.02B |
| EBITDA | 2.35B |
| Net Income | 1.29B |
| Diluted EPS | 12 |
Balance Sheet
| Total Cash | 1.93B |
| Total Cash/Share | 18.14 |
| Total Debt | 225.57M |
| Total Debt/Equity | 0.02 |
| Current Ratio | 4.35 |
| Book Value Per Share | 125.36 |
Price History
| 52-Week Change | 320.97 |
| 52-Week High | 739.9 |
| 52-Week Low | 140.8 |
| Moving Average 50 Days | 665.33 |
| Moving Average 200 Days | 432.46 |
Statistics
| Average Volume | 332,590 |
| Shares Outstanding | 106.33M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 1.5 |
| Trailing Annual Dividend Yield | 0.23 |
| Payout Ratio | 0.03 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
